| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |